Psychosocial Distress and Distress Screening in Multidisciplinary Head and Neck Cancer Treatment: Psychosocial distress screening (DS) for cancer and head and neck cancer (HNC) patients is rapidly becoming the standard of care. DS is of particular importance for patients with HNC, given their heightened incidence of distress, depression, anxiety, suicide, quality of life impacts, and negative medical outcomes. In the absence of DS, distress is frequently missed in oncology settings. However, when identified, distress is highly responsive to treatment, with cognitive behavioral and behavioral medicine interventions demonstrating evidence of efficacy. Multidisciplinary HNC teams are uniquely positioned to implement effective DS programs and treatment tailored to HNC patients’ psychological and medical vulnerabilities.
http://ift.tt/2uzyekl
Ιατρική : Τα αισθητικά συστήματα της όρασης,ακοής,αφής,γεύσης και όσφρησης.
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Subcutaneous zygomycosis presenting as soft-tissue ‘tumour’ over scapula – case report and review of literature : 2016-10-06T18-09-02Z Sou...
-
Abstract Objectives We examined the effect of biologic disease-modifying anti-rheumatic drugs on the time to pregnancy in patients with ...
-
Publication date: Available online 2 August 2017 Source: Neuroscience Research Author(s): Mamoru Takeda, Masanori Nasu, Takuya Kanazawa, ...
-
Immune response profile of primary tumour, sentinel and non-sentinel axillary lymph nodes related to metastasis in breast cancer: an immunoh...
-
Abstract Objectives We present an overview of the literature on caregiver stress in children with craniosynostosis and report common tre...
-
Abstract Background In order to gain insight into the early effects drawn by JAK inhibitors on intra-joint JAK/STAT-dependent signaling,...
-
Abstract Introduction We report a pure distraction injury of the upper thoracic spine and uncontrolled hyperthermia without an infectious...
-
A novel urotensin II receptor antagonist, KR-36676, prevents ABCA1 repression via ERK/IL-1β pathway.Related Articles A novel urotensin II receptor antagonist, KR-36676, prevents ABCA1 repression via ERK/IL-1β pathway. Eur J Pharmacol...
-
Abstract Limited literature is available on the use of fine needle aspiration (FNA) for skin tumors. Awareness of cytological features of ...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου